Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan L Roth

Showing results (1-10 of 450) with videos related to

Pageof 45
Sort By:
Neuropharmacology|February 4, 2011
Irving Page Lecture: 5-HT(2A) serotonin receptor biology: interacting proteins, kinases and paradoxical regulationBryan L Roth
Pharmacology & Therapeutics|August 9, 2005
Receptor systems: will mining the receptorome yield novel targets for pharmacotherapy?Bryan L Roth
Neuron|February 19, 2016
DREADDs for NeuroscientistsBryan L Roth
The Journal of Clinical Psychiatry|March 28, 2008
High-dose olanzapine for treatment-resistant schizophreniaBryan L Roth
Biochemistry|June 8, 2026
GPCR Biased Signaling: Opportunities and ChallengesBryan L Roth
Nature Structural & Molecular Biology|July 5, 2019
Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugsBryan L Roth
Dialogues in Clinical Neuroscience|November 23, 2006
Contributions of molecular biology to antipsychotic drug discovery: promises fulfilled or unfulfilled?Bryan L Roth
The New England Journal of Medicine|January 5, 2007
Drugs and valvular heart diseaseBryan L Roth
ACS Medicinal Chemistry Letters|April 2, 2013
Impossible or merely difficult? Two grand challenges from a biologist's perspectiveBryan L Roth
Current Opinion in Structural Biology|March 1, 2019
How structure informs and transforms chemogeneticsBryan L Roth
Pageof 45

Showing results (1-10 of 450) with videos related to

Sort By:
Pageof 45
Neuropharmacology|February 4, 2011
Irving Page Lecture: 5-HT(2A) serotonin receptor biology: interacting proteins, kinases and paradoxical regulationBryan L Roth
Pharmacology & Therapeutics|August 9, 2005
Receptor systems: will mining the receptorome yield novel targets for pharmacotherapy?Bryan L Roth
Neuron|February 19, 2016
DREADDs for NeuroscientistsBryan L Roth
The Journal of Clinical Psychiatry|March 28, 2008
High-dose olanzapine for treatment-resistant schizophreniaBryan L Roth
Biochemistry|June 8, 2026
GPCR Biased Signaling: Opportunities and ChallengesBryan L Roth
Nature Structural & Molecular Biology|July 5, 2019
Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugsBryan L Roth
Dialogues in Clinical Neuroscience|November 23, 2006
Contributions of molecular biology to antipsychotic drug discovery: promises fulfilled or unfulfilled?Bryan L Roth
The New England Journal of Medicine|January 5, 2007
Drugs and valvular heart diseaseBryan L Roth
ACS Medicinal Chemistry Letters|April 2, 2013
Impossible or merely difficult? Two grand challenges from a biologist's perspectiveBryan L Roth
Current Opinion in Structural Biology|March 1, 2019
How structure informs and transforms chemogeneticsBryan L Roth
Pageof 45